Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Lymphoma × Immunotherapy, Active × Clear all

Phase

Status

Sponsor Class

NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma 1

Interventions

Rituximab 57 Cyclophosphamide 34 fludarabine 20 Bendamustine Hydrochloride 20 pembrolizumab 18 Brentuximab Vedotin 18 Gemcitabine 17 Prednisone 16 Doxorubicin 16 ibrutinib 15 obinutuzumab 14 Vincristine 13 Nivolumab 9 Lenalidomide 9 parsaclisib 7 atezolizumab 7 Rifampin 7 Dexamethasone 7 Azacitidine 7 spartalizumab 6 loncastuximab tesirine 6 duvelisib 6 Vorinostat 6 MLN 8237 6 venetoclax 5 Etoposide 5 zanubrutinib 4 rasburicase 4 ixazomib 4 idelalisib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00036426 2005-06-24

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Favrille

Phase 2 Unknown

Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡